|
FY2026
12 months to Jan 31, 2026
|
|
|---|---|
| Cash flows from operating activities: | |
| Net loss | |
| Adjustments to reconcile net loss to net cash provided by (used in) operating activities: | |
| Stock-based compensation, net of amounts capitalized | |
| Non-cash interest expense | |
| Deferred income taxes | |
| Depreciation and amortization | |
| Amortization of contract acquisition costs | |
| Provision for doubtful accounts | |
| Loss (gain) on fair value adjustments | |
| Debt issuance costs expensed related to SAFEs | |
| Loss on extinguishment of debt | |
| Other | |
| Changes in operating assets and liabilities, net of effect of business acquisitions: | |
| Accounts receivable | |
| Prepaid expenses and other current assets | |
| Contract acquisition costs | |
| Other non-current assets | |
| Accounts payable | |
| Accrued expenses and other current liabilities | |
| Deferred revenue | |
| Operating lease right-of-use asset and operating lease liabilities, net | |
| Other non-current liabilities | |
| Net cash provided by (used in) operating activities | |
| Cash flows from investing activities: | |
| Capitalized software development costs | |
| Purchases of property and equipment | |
| Purchases of investments | |
| (Increase) decrease in corporate card receivables | |
| Cash consideration for business acquisition, net of cash acquired | |
| Other | |
| Net cash (used in) provided by investing activities | |
| Cash flows from financing activities: | |
| Proceeds from stock option exercises | |
| Proceeds from borrowings of debt | |
| Proceeds from issuance of SAFEs | |
| Payments of borrowings of debt | |
| Payments for debt issuance costs | |
| Payments of deferred offering costs | |
| Payment of deferred consideration in business combinations | |
| Proceeds from issuance of common stock in IPO, net of underwriting costs | |
| Taxes collected from selling shareholders stock option exercises | |
| Taxes remitted for selling shareholders stock option exercises | |
| Payment of tax withholdings on settlement of RSUs | |
| Proceeds from exercise of warrants | |
| Net cash provided by financing activities | |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | |
| Net increase (decrease) in cash, cash equivalents and restricted cash | |
| Cash, cash equivalents and restricted cash, beginning of period | |
| Cash, cash equivalents and restricted cash, end of period | |
| Supplemental disclosure of cash flow information: | |
| Cash paid for interest | |
| Cash paid for income taxes | |
| Noncash investing and financing activities: | |
| Vesting of early exercised stock options | |
| Capitalized stock-based compensation for internal-use software development costs | |
| Deferred offering costs not yet paid | |
| Conversion of redeemable convertible preferred stock to common stock | |
| Conversion of SAFEs to equity upon IPO | |
| Reclassification of preferred stock warrants & SAFE warrants to equity upon IPO | |
| Conversion of convertible notes to equity upon IPO |
Loading...
